XML 125 R111.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                      
General and administrative expenses                 $ (220.2) $ (171.7) $ (133.4)
Depreciation and amortization                 (199.7) (183.8) (172.6)
Government, class action, and related settlements                 (52.0) 0.0 0.0
Loss on early extinguishment of debt                 0.0 (10.7) (7.4)
Net income attributable to noncontrolling interests $ 19.6 $ 20.7 $ 21.4 $ 21.4 $ 25.9 $ 19.2 $ 16.4 $ 17.6 83.1 79.1 70.5
Income from continuing operations before income tax expense                 493.2 496.4 482.0
Inpatient Rehabilitation Hospital and Home Health and Hospice [Member]                      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                      
Total segment Adjusted EBITDA                 1,034.3 947.1 899.6
Segment Reconciling Items [Member]                      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                      
General and administrative expenses                 (220.2) (171.7) (133.4)
Depreciation and amortization                 (199.7) (183.8) (172.6)
Loss on disposal of assets                 (5.7) (4.6) (0.7)
Government, class action, and related settlements                 (52.0) 0.0 0.0
Professional fees—accounting, tax, and legal                 0.0 0.0 (1.9)
Loss on early extinguishment of debt                 0.0 (10.7) (7.4)
Interest expense and amortization of debt discounts and fees                 (147.3) (154.4) (172.1)
Net income attributable to noncontrolling interests                 83.1 79.1 70.5
SARs mark-to-market impact on noncontrolling interests                 2.6 0.0 0.0
Change in fair market value of equity securities                 (1.9) 0.0 0.0
Tax reform impact on noncontrolling interests                 $ 0.0 $ (4.6) $ 0.0